Literature DB >> 8539422

Psychosis in Parkinson's disease: diagnosis and treatment.

M Doraiswamy1, W Martin, A Metz, J Deveaugh-Geiss.   

Abstract

1. This article reviews the prevalence, diagnosis, pathophysiology and management of psychosis in Parkinson's disease. 2. Psychosis in Parkinson's disease has been associated with all antiparkinsonian medications. The most common symptoms are vivid disturbing dreams, visual hallucinations and paranoid delusions. 3. The emergence of psychosis reduces the patient's functional capacity and increases caregiver burden. It also poses a therapeutic dilemma because effective treatment of psychotic symptoms may result in worsening of motor symptoms and vice versa. 4. Increased physician awareness is essential for proper diagnosis and management. Withdrawal of anticholinergic medications and amantadine followed by levodopa dose adjustment is effective in many patients. 5. Atypical neuroleptics, in low doses, may be successful when other measures have failed. However, these agents are not approved for treating Parkinsonian psychosis and must be considered as investigational therapies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539422     DOI: 10.1016/0278-5846(95)00114-b

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  3 in total

1.  Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease.

Authors:  D Brandstaedter; S Spieker; G Ulm; U Siebert; T E Eichhorn; J C Krieg; W H Oertel; K Eggert
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

2.  Cost effectiveness of pramipexole in Parkinson's disease in the US.

Authors:  T J Hoerger; M V Bala; C Rowland; M Greer; E A Chrischilles; R G Holloway
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

Review 3.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.